CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 527 of 865
Non-Antibody Products
Page 527 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| MRT67307 (hydrochloride) | A kinase inhibitor that inhibits TBK1, MARK1-4, IKKε, and NUAK1 (I… | 5 mg | 19916-5 | More Info |
| MRTX-1133 | An inhibitor of K-RasG12D; selectively reduces ERK phosphorylation in AsPC… | 1 mg | 36413-1 | More Info |
| MRTX-1133 | An inhibitor of K-RasG12D; selectively reduces ERK phosphorylation in AsPC… | 10 mg | 36413-10 | More Info |
| MRTX-1133 | An inhibitor of K-RasG12D; selectively reduces ERK phosphorylation in AsPC… | 5 mg | 36413-5 | More Info |
| MRTX-1257 | A covalent inhibitor of K-RasG12C; inhibits proliferation of NCI H358 cell… | 1 mg | 33527-1 | More Info |
| MRTX-1257 | A covalent inhibitor of K-RasG12C; inhibits proliferation of NCI H358 cell… | 10 mg | 33527-10 | More Info |
| MRTX-1257 | A covalent inhibitor of K-RasG12C; inhibits proliferation of NCI H358 cell… | 25 mg | 33527-25 | More Info |
| MRTX-1257 | A covalent inhibitor of K-RasG12C; inhibits proliferation of NCI H358 cell… | 5 mg | 33527-5 | More Info |
| MRTX-849 | A covalent inhibitor of K-RasG12C; binds to and stabilizes GDP-bound inact… | 1 mg | 31440-1 | More Info |
| MRTX-849 | A covalent inhibitor of K-RasG12C; binds to and stabilizes GDP-bound inact… | 10 mg | 31440-10 | More Info |
| MRTX-849 | A covalent inhibitor of K-RasG12C; binds to and stabilizes GDP-bound inact… | 5 mg | 31440-5 | More Info |
| MRTX-0902 | An inhibitor of the SOS1-K-RasG12C protein-protein interaction (Ki = 1.9 n… | 1 mg | 38578-1 | More Info |
| MRTX-0902 | An inhibitor of the SOS1-K-RasG12C protein-protein interaction (Ki = 1.9 n… | 10 mg | 38578-10 | More Info |
| MRTX-0902 | An inhibitor of the SOS1-K-RasG12C protein-protein interaction (Ki = 1.9 n… | 25 mg | 38578-25 | More Info |
| MRTX-0902 | An inhibitor of the SOS1-K-RasG12C protein-protein interaction (Ki = 1.9 n… | 5 mg | 38578-5 | More Info |
| MRX-2843 | A Mer and FLT3 inhibitor (IC50s = 1.3 and 1 nM, respectively); inhibits Ax… | 1 mg | 27923-1 | More Info |
| MRX-2843 | A Mer and FLT3 inhibitor (IC50s = 1.3 and 1 nM, respectively); inhibits Ax… | 10 mg | 27923-10 | More Info |
| MRX-2843 | A Mer and FLT3 inhibitor (IC50s = 1.3 and 1 nM, respectively); inhibits Ax… | 5 mg | 27923-5 | More Info |
| MS023 | An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… | 10 mg | 34786-10 | More Info |
| MS023 | An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… | 25 mg | 34786-25 | More Info |
| MS023 | An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… | 5 mg | 34786-5 | More Info |
| MS023 | An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… | 50 mg | 34786-50 | More Info |
| MS-1020 | A cell-permeable inhibitor of JAK3, strongly inhibiting constitutive autop… | 1 mg | 14273-1 | More Info |
| MS1943 | A PROTAC that drives EZH2 degradation; inhibits EZH2 (IC50 = 120 nM) and i… | 1 mg | 35466-1 | More Info |
| MS1943 | A PROTAC that drives EZH2 degradation; inhibits EZH2 (IC50 = 120 nM) and i… | 10 mg | 35466-10 | More Info |
| MS1943 | A PROTAC that drives EZH2 degradation; inhibits EZH2 (IC50 = 120 nM) and i… | 25 mg | 35466-25 | More Info |
| MS1943 | A PROTAC that drives EZH2 degradation; inhibits EZH2 (IC50 = 120 nM) and i… | 5 mg | 35466-5 | More Info |
| MS-275 | An inhibitor of HDACs that preferentially inhibits HDAC1 (IC50 = 300 nM) o… | 1 mg | 13284-1 | More Info |
| MS-275 | An inhibitor of HDACs that preferentially inhibits HDAC1 (IC50 = 300 nM) o… | 10 mg | 13284-10 | More Info |
| MS-275 | An inhibitor of HDACs that preferentially inhibits HDAC1 (IC50 = 300 nM) o… | 25 mg | 13284-25 | More Info |
| MS-275 | An inhibitor of HDACs that preferentially inhibits HDAC1 (IC50 = 300 nM) o… | 5 mg | 13284-5 | More Info |
| MS37452 | A competitive inhibitor of CBX7 chromodomain binding to H3K27me3 (Ki = 43… | 1 mg | 17533-1 | More Info |
| MS37452 | A competitive inhibitor of CBX7 chromodomain binding to H3K27me3 (Ki = 43… | 10 mg | 17533-10 | More Info |
| MS37452 | A competitive inhibitor of CBX7 chromodomain binding to H3K27me3 (Ki = 43… | 25 mg | 17533-25 | More Info |
| MS37452 | A competitive inhibitor of CBX7 chromodomain binding to H3K27me3 (Ki = 43… | 5 mg | 17533-5 | More Info |
| MSA-2 | A STING agonist; binds to wild-type and HAQ variant STING in a 3H-cGAMP fi… | 1 mg | 30140-1 | More Info |
| MSA-2 | A STING agonist; binds to wild-type and HAQ variant STING in a 3H-cGAMP fi… | 10 mg | 30140-10 | More Info |
| MSA-2 | A STING agonist; binds to wild-type and HAQ variant STING in a 3H-cGAMP fi… | 5 mg | 30140-5 | More Info |
| MSAB | An inhibitor of Wnt/β-catenin signaling; selectively inhibits the pro… | 10 mg | 36497-10 | More Info |
| MSAB | An inhibitor of Wnt/β-catenin signaling; selectively inhibits the pro… | 100 mg | 36497-100 | More Info |
| MSAB | An inhibitor of Wnt/β-catenin signaling; selectively inhibits the pro… | 25 mg | 36497-25 | More Info |
| MSAB | An inhibitor of Wnt/β-catenin signaling; selectively inhibits the pro… | 50 mg | 36497-50 | More Info |
| MSC2530818 | A Cdk8 inhibitor (IC50 = 2.6 nM); selective for Cdk8 over a panel of 264 k… | 1 mg | 29669-1 | More Info |
| MSC2530818 | A Cdk8 inhibitor (IC50 = 2.6 nM); selective for Cdk8 over a panel of 264 k… | 10 mg | 29669-10 | More Info |
| MSC2530818 | A Cdk8 inhibitor (IC50 = 2.6 nM); selective for Cdk8 over a panel of 264 k… | 25 mg | 29669-25 | More Info |
| MSC2530818 | A Cdk8 inhibitor (IC50 = 2.6 nM); selective for Cdk8 over a panel of 264 k… | 5 mg | 29669-5 | More Info |
| MSDC-0160 | A thiazolidinedione; inactivates MPC (IC50 = 1.2 µM) without affecti… | 1 mg | 71748-1 | More Info |
| MSDC-0160 | A thiazolidinedione; inactivates MPC (IC50 = 1.2 µM) without affecti… | 10 mg | 71748-10 | More Info |
| MSDC-0160 | A thiazolidinedione; inactivates MPC (IC50 = 1.2 µM) without affecti… | 5 mg | 71748-5 | More Info |
| MSDC-0602 | A PPARγ-sparing thiazolidinedione derivative; binds only weakly to P… | 10 mg | 27829-10 | More Info |
| MSDC-0602 | A PPARγ-sparing thiazolidinedione derivative; binds only weakly to P… | 100 mg | 27829-100 | More Info |
| MSDC-0602 | A PPARγ-sparing thiazolidinedione derivative; binds only weakly to P… | 25 mg | 27829-25 | More Info |
| MSDC-0602 | A PPARγ-sparing thiazolidinedione derivative; binds only weakly to P… | 50 mg | 27829-50 | More Info |
| MS023 (hydrochloride) | An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… | 1 mg | 18361-1 | More Info |
| MS023 (hydrochloride) | An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… | 10 mg | 18361-10 | More Info |
| MS023 (hydrochloride) | An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… | 25 mg | 18361-25 | More Info |
| MS023 (hydrochloride) | An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… | 5 mg | 18361-5 | More Info |
| MS049 (hydrochloride) | A selective inhibitor of PRMT4 (IC50 = 34 nM) and PRMT6 (IC50 = 43 nM); re… | 1 mg | 18348-1 | More Info |
| MS049 (hydrochloride) | A selective inhibitor of PRMT4 (IC50 = 34 nM) and PRMT6 (IC50 = 43 nM); re… | 10 mg | 18348-10 | More Info |
| MS049 (hydrochloride) | A selective inhibitor of PRMT4 (IC50 = 34 nM) and PRMT6 (IC50 = 43 nM); re… | 25 mg | 18348-25 | More Info |
| MS049 (hydrochloride) | A selective inhibitor of PRMT4 (IC50 = 34 nM) and PRMT6 (IC50 = 43 nM); re… | 5 mg | 18348-5 | More Info |
| MS 245 (oxalate) | An antagonist of 5-HT6 (Ki = 2.3 nM for the human recombinant receptor); s… | 1 mg | 11936-1 | More Info |
| MS 245 (oxalate) | An antagonist of 5-HT6 (Ki = 2.3 nM for the human recombinant receptor); s… | 10 mg | 11936-10 | More Info |
| MS 245 (oxalate) | An antagonist of 5-HT6 (Ki = 2.3 nM for the human recombinant receptor); s… | 5 mg | 11936-5 | More Info |
| MS-PPOH | Arachidonic acid is converted by microsomal CYP450 enzymes to a variety of… | 1 mg | 75770-1 | More Info |
| MS-PPOH | Arachidonic acid is converted by microsomal CYP450 enzymes to a variety of… | 10 mg | 75770-10 | More Info |
| MS-PPOH | Arachidonic acid is converted by microsomal CYP450 enzymes to a variety of… | 5 mg | 75770-5 | More Info |
| MS-PPOH | Arachidonic acid is converted by microsomal CYP450 enzymes to a variety of… | 50 mg | 75770-50 | More Info |
| MST-312 | A telomerase inhibitor (IC50 = 0.67 µM in a TRAP assay); selective f… | 10 mg | 24301-10 | More Info |
| MST-312 | A telomerase inhibitor (IC50 = 0.67 µM in a TRAP assay); selective f… | 5 mg | 24301-5 | More Info |
| MSX-122 | A partial antagonist of CXCR4; reduces inflammation in a mouse model of ex… | 1 mg | 23426-1 | More Info |
| MSX-122 | A partial antagonist of CXCR4; reduces inflammation in a mouse model of ex… | 10 mg | 23426-10 | More Info |
| MSX-122 | A partial antagonist of CXCR4; reduces inflammation in a mouse model of ex… | 25 mg | 23426-25 | More Info |
| MSX-122 | A partial antagonist of CXCR4; reduces inflammation in a mouse model of ex… | 5 mg | 23426-5 | More Info |
| MSX-130 | An imidazole; displays excitation / emission maxima of 382 / 466 nm, respe… | 10 mg | 36804-10 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile